The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease
Open accessAbstract
Metabolic perturbations underlie a variety of cardiovascular disease states; yet, metabolic interventions to prevent or treat these disorders are sparse. Ketones carry a negative clinical stigma as they are involved in diabetic ketoacidosis. However, evidence from both experimental and clinical research has uncovered a protective role for ketones in cardiovascular disease. Although ketones may provide supplemental fuel for the energy-starved heart, their cardiovascular effects appear to extend far beyond cardiac energetics. Indeed, ketone bodies have been shown to influence a variety of cellular processes including gene transcription, inflammation and oxidative stress, endothelial function, cardiac remodeling, and cardiovascular risk factors. This paper reviews the bioenergetic and pleiotropic effects of ketone bodies that could potentially contribute to its cardiovascular benefits based on evidence from animal and human studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardiovascular and renal outcomes with empagliflozin in heart failure
Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., Januzzi, J., Verma, S., Tsutsui, H., Brueckmann, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022190 · Cited by 5,206
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172
A Randomized Trial of a Low-Carbohydrate Diet for Obesity
Foster, G. D., Wyatt, H. R., Hill, J. O., McGuckin, B. G., Brill, C., Mohammed, B. S., Szapary, P. O., Rader, D. J., Edman, J. S., & Klein, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022207 · Cited by 1,794
A Low-Carbohydrate as Compared with a Low-Fat Diet in Severe Obesity
Samaha, F. F., Iqbal, N., Seshadri, P., Chicano, K. L., Daily, D. A., McGrory, J., Williams, T., Williams, M., Gracely, E. J., & Stern, L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022637 · Cited by 1,267
Physiological roles of ketone bodies as substrates and signals in mammalian tissues.
Robinson, A. M., & Williamson, D. H. (1980) · Physiological Reviews · doi:10.1152/physrev.1980.60.1.143 · Cited by 1,012
Bonner, C., Kerr-Conte, J., Gmyr, V., Queniat, G., Moerman, E., Thévenet, J., Beaucamps, C., Delalleau, N., Popescu, I., Malaisse, W. J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3828 · Cited by 670
Comprehensive quantification of fuel use by the failing and nonfailing human heart
Murashige, D., Jang, C., Neinast, M., Edwards, J. J., Cowan, A., Hyman, M. C., Rabinowitz, J. D., Frankel, D. S., & Arany, Z. (2020) · Science · doi:10.1126/science.abc8861 · Cited by 580
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes
Cox, P. J., Kirk, T., Ashmore, T., Willerton, K., Evans, R., Smith, A., Murray, A. J., Stubbs, B., West, J., McLure, S. W., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.010 · Cited by 530
A high-fat, ketogenic diet induces a unique metabolic state in mice
Kennedy, A. R., Pissios, P., Otu, H., Xue, B., Asakura, K., Furukawa, N., Marino, F. E., Liu, F.-F., Kahn, B. B., Libermann, T. A., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00717.2006 · Cited by 420
Forsythe, C. E., Phinney, S. D., Fernandez, M. L., Quann, E. E., Wood, R. J., Bibus, D. M., Kraemer, W. J., Feinman, R. D., & Volek, J. S. (2008) · Lipids · doi:10.1007/s11745-007-3132-7 · Cited by 371
Research works printed but not linked: 77
- Puchalska, 2017, Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics, Cell Metab, 25, 262, 10.1016/j.cmet.2016.12.022 · DOI · Paper page
- Horton, 2019, The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense, JCI Insight, 4, 10.1172/jci.insight.124079 · DOI · Paper page
- Nielsen, 2019, Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients, Circulation, 139, 2129, 10.1161/CIRCULATIONAHA.118.036459 · DOI · Paper page
- Gormsen, 2017, Ketone body infusion with 3-hydroxybutyrate reduces myocardial glucose uptake and increases blood flow in humans: a positron emission tomography study, J Am Heart Assoc, 6
- Yurista, 2019, Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction, Eur J Heart Fail, 21, 862, 10.1002/ejhf.1473 · DOI · Paper page
- Bhanpuri, 2018, Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study, Cardiovasc Diabetol, 17, 56, 10.1186/s12933-018-0698-8 · DOI · Paper page
- Gjuladin-Hellon, 2019, Effects of carbohydrate-restricted diets on low-density lipoprotein cholesterol levels in overweight and obese adults: a systematic review and meta-analysis, Nutr Rev, 77, 161, 10.1093/nutrit/nuy049 · DOI · Paper page
- Balasse, 1989, Ketone body production and disposal: effects of fasting, diabetes, and exercise, Diabetes Metab Rev, 5, 247, 10.1002/dmr.5610050304 · DOI · Paper page
- Abdul Kadir, 2020, Cardiac ketone body metabolism, Biochim Biophys Acta - Mol Basis Dis, 1866, 165739, 10.1016/j.bbadis.2020.165739 · DOI
- Selvaraj, 2020, Implications of altered ketone metabolism and therapeutic ketosis in heart failure, Circulation, 141, 1800, 10.1161/CIRCULATIONAHA.119.045033 · DOI · Paper page
- Rudolph, 1965, On the significance of acetoacetate and beta-hydroxybutyrate in human myocardial metabolism, Klin Wochenschr, 43, 445, 10.1007/BF01483852 · DOI
- Sack, 1996, Fatty acid oxidation enzyme gene expression is downregulated in the failing heart, Circulation, 94, 2837, 10.1161/01.CIR.94.11.2837 · DOI · Paper page
- Epstein, 1994, Inherited cardiomyopathies, N Engl J Med, 330, 913, 10.1056/NEJM199403313301308 · DOI · Paper page
- Bedi, 2016, Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure, Circulation, 133, 706, 10.1161/CIRCULATIONAHA.115.017545 · DOI · Paper page
- Aubert, 2016, The failing heart relies on ketone bodies as a fuel, Circulation, 133, 698, 10.1161/CIRCULATIONAHA.115.017355 · DOI · Paper page
- Lommi, 1996, Blood ketone bodies in congestive heart failure, J Am Coll Cardiol, 28, 665, 10.1016/0735-1097(96)00214-8 · DOI · Paper page
- Voros, 2018, Increased cardiac uptake of ketone bodies and free fatty acids in human heart failure and hypertrophic left ventricular remodeling, Circ Heart Fail, 11, 10.1161/CIRCHEARTFAILURE.118.004953 · DOI
- Marcondes-Braga, 2016, Impact of exhaled breath acetone in the prognosis of patients with heart failure with reduced ejection fraction (HFrEF). One year of clinical follow-up, PLoS One, 11, 10.1371/journal.pone.0168790 · DOI
- Song, 2020, Elevated plasma β-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy, Sci Transl Med, 12, 10.1126/scitranslmed.aay8329 · DOI
- Mizuno, 2017, The diabetic heart utilizes ketone bodies as an energy source, Metabolism, 77, 65, 10.1016/j.metabol.2017.08.005 · DOI
- Ho, 2019, Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency, Cardiovasc Res, 115, 1606, 10.1093/cvr/cvz045 · DOI · Paper page
- Kwiterovich, 2003, Effect of a High-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children, JAMA, 290, 912, 10.1001/jama.290.7.912 · DOI · Paper page
- Shaw, 2019, The effect of 1,3-butanediol on cycling time-trial performance, Int J Sport Nutr Exerc Metab, 29, 466, 10.1123/ijsnem.2018-0284 · DOI
- Scott, 2019, The effect of 1,3-butanediol and carbohydrate supplementation on running performance, J Sci Med Sport, 22, 702, 10.1016/j.jsams.2018.11.027 · DOI
- Cunnane, 2016, Can ketones help rescue brain fuel supply in later life? implications for cognitive health during aging and the treatment of Alzheimer’s disease, Front Mol Neurosci, 9, 53, 10.3389/fnmol.2016.00053 · DOI · Paper page
- Harvey CJ, 2018, The effect of medium chain triglycerides on time to nutritional ketosis and symptoms of keto-induction in healthy adults: a randomised controlled clinical trial, J Nutr Metab, 2018, 1, 10.1155/2018/2630565 · DOI
- Stubbs, 2019, Gastrointestinal effects of exogenous ketone drinks are infrequent, mild, and vary according to ketone compound and dose, Int J Sport Nutr Exerc Metab, 29, 596, 10.1123/ijsnem.2019-0014 · DOI
- Ferrannini, 2016, Shift to fatty substrate utilization in response to sodium–glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes, Diabetes, 65, 1190, 10.2337/db15-1356 · DOI · Paper page
- Lopaschuk, 2020, Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors, J Am Coll Cardiol Basic Transl Sci, 5, 632
- Santos-Gallego, 2019, Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial energetics, J Am Coll Cardiol, 73, 1931, 10.1016/j.jacc.2019.01.056 · DOI · Paper page
- Kim, 2020, SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease, Nat Commun, 11, 2127, 10.1038/s41467-020-15983-6 · DOI · Paper page
- Shimazu, 2013, Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor, Science, 339, 211, 10.1126/science.1227166 · DOI · Paper page
- Mccarthy, 2019, Abstract 829.1: β-hydroxybutyrate (βHOB) increases nitric oxide synthase activity in resistance arteries from dahl salt-sensitive rats [abstr], FASEB J, 33, 10.1096/fasebj.2019.33.1_supplement.829.1 · doi:10.1096/fasebj.2019.33.1_supplement.829.1
- Hasselbalch, 1996, Transport of D-glucose and 2-fluorodeoxyglucose across the blood-brain barrier in humans, J Cereb Blood Flow Metab, 16, 659, 10.1097/00004647-199607000-00017 · doi:10.1097/00004647-199607000-00017
- Fioretto, 1987, Glomerular filtration rate is increased in man by the infusion of both D,L-3-hydroxybutyric acid and sodium D,L-3-hydroxybutyrate, J Clin Endocrinol Metab, 65, 331, 10.1210/jcem-65-2-331 · DOI
- Ma, 2018, Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice, Sci Rep, 8, 6670, 10.1038/s41598-018-25190-5 · DOI · Paper page
- Uchihashi, 2017, Cardiac-specific Bdh1 overexpression ameliorates oxidative stress and cardiac remodeling in pressure overload–induced heart failure, Circ Hear Fail, 10
- Yu, 2018, Treatment with D-β-hydroxybutyrate protects heart from ischemia/reperfusion injury in mice, Eur J Pharmacol, 829, 121, 10.1016/j.ejphar.2018.04.019 · DOI
- Krebs, 2011, Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet, Proc Natl Acad Sci U S A, 108, 19678, 10.1073/pnas.1117835108 · DOI
- Al-Zaid, 2007, Low carbohydrate ketogenic diet enhances cardiac tolerance to global ischaemia, Acta Cardiol, 62, 381, 10.2143/AC.62.4.2022282 · DOI
- Mezzaroma, 2011, The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse, Proc Natl Acad Sci U S A, 108, 19725, 10.1073/pnas.1108586108 · DOI · Paper page
- Bae, 2016, β-Hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation, Oncotarget, 7, 66444, 10.18632/oncotarget.12119 · DOI · Paper page
- Cohn, 2000, Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling, J Am Coll Cardiol, 35, 569, 10.1016/S0735-1097(99)00630-0 · DOI · Paper page
- Duda, 2008, Low-carbohydrate/high-fat diet attenuates pressure overload–induced ventricular remodeling and dysfunction, J Card Fail, 14, 327, 10.1016/j.cardfail.2007.11.003 · DOI
- Snorek, 2012, Short-term fasting reduces the extent of myocardial infarction and incidence of reperfusion arrhythmias in rats, Physiol Res, 61, 567, 10.33549/physiolres.932338 · DOI
- Schugar, 2014, Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling, Mol Metab, 3, 754, 10.1016/j.molmet.2014.07.010 · DOI · Paper page
- Yurista, 2021, Ketone ester treatment improves cardiac function and reduces pathologic remodeling in preclinical models of heart failure, Circ Hear Fail, 14, e007684, 10.1161/CIRCHEARTFAILURE.120.007684 · DOI
- Guo, 2020, Ketogenic diet ameliorates cardiac dysfunction via balancing mitochondrial dynamics and inhibiting apoptosis in type 2 diabetic mice, Aging Dis, 11, 229, 10.14336/AD.2019.0510 · DOI
- Xie, 2013, HDAC-dependent ventricular remodeling, Trends Cardiovasc Med, 23, 229, 10.1016/j.tcm.2012.12.006 · DOI
- Kong, 2006, Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy, Circulation, 113, 2579, 10.1161/CIRCULATIONAHA.106.625467 · DOI · Paper page
- Wallner, 2020, HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction, Sci Transl Med, 12, 10.1126/scitranslmed.aay7205 · DOI
- Chakraborty, 2018, Salt-responsive metabolite, β-hydroxybutyrate, attenuates hypertension, Cell Rep, 25, 677, 10.1016/j.celrep.2018.09.058 · DOI · Paper page
- Cicero, 2015, Middle and long-term impact of a very low-carbohydrate ketogenic diet on cardiometabolic factors: a multi-center, cross-sectional, clinical study, High Blood Press Cardiovasc Prev, 22, 389, 10.1007/s40292-015-0096-1 · DOI
- Davis, 2019, Dietary R, S -1,3-butanediol diacetoacetate reduces body weight and adiposity in obese mice fed a high-fat diet, FASEB J, 33, 2409, 10.1096/fj.201800821RR · DOI
- Deemer, 2019, Concentration-dependent effects of a dietary ketone ester on components of energy balance in mice, Front Nutr, 6, 56, 10.3389/fnut.2019.00056 · DOI
- Srivastava, 2012, Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet, FASEB J, 26, 2351, 10.1096/fj.11-200410 · DOI
- Kashiwaya, 2010, A ketone ester diet increases brain malonyl-coa and uncoupling proteins 4 and 5 while decreasing food intake in the normal wistar rat, J Biol Chem, 285, 25950, 10.1074/jbc.M110.138198 · DOI
- Stubbs, 2018, A ketone ester drink lowers human ghrelin and appetite, Obesity (Silver Spring), 26, 269, 10.1002/oby.22051 · DOI · Paper page
- Caminhotto, 2017, Oral β-hydroxybutyrate increases ketonemia, decreases visceral adipocyte volume and improves serum lipid profile in Wistar rats, Nutr Metab (Lond), 14, 31, 10.1186/s12986-017-0184-4 · DOI
- Douris, 2015, Adaptive changes in amino acid metabolism permit normal longevity in mice consuming a low-carbohydrate ketogenic diet, Biochim Biophys Acta - Mol Basis Dis, 1852, 2056, 10.1016/j.bbadis.2015.07.009 · DOI
- Shimizu, 2018, Short-term and long-term ketogenic diet therapy and the addition of exercise have differential impacts on metabolic gene expression in the mouse energy-consuming organs heart and skeletal muscle, Nutr Res, 60, 77, 10.1016/j.nutres.2018.09.004 · DOI
- Ari, 2019, Exogenous ketones lower blood glucose level in rested and exercised rodent models, Nutrients, 11, 2330, 10.3390/nu11102330 · DOI
- É, 2019, A ketone monoester drink reduces the glycemic response to an oral glucose challenge in individuals with obesity: a randomized trial, Am J Clin Nutr, 110, 1491, 10.1093/ajcn/nqz232 · DOI
- É, 2018, Prior ingestion of exogenous ketone monoester attenuates the glycaemic response to an oral glucose tolerance test in healthy young individuals, J Physiol, 596, 1385, 10.1113/JP275709 · DOI
- Jornayvaz, 2010, A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain, Am J Physiol Metab, 299, E808
- Bielohuby, 2013, Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets, Am J Physiol Metab, 305, E1059
- Churuangsuk, 2020, Lower carbohydrate and higher fat intakes are associated with higher hemoglobin A1c: findings from the UK National Diet and Nutrition Survey 2008-2016, Eur J Nutr, 59, 2771, 10.1007/s00394-019-02122-1 · DOI
- Desrochers, 1995, Metabolism of (R,S)-1,3-butanediol acetoacetate esters, potential parenteral and enteral nutrients in conscious pigs, Am J Physiol Metab, 268, E660
- Stubbs, 2017, On the metabolism of exogenous ketones in humans, Front Physiol, 8, 848, 10.3389/fphys.2017.00848 · DOI · Paper page
- Ellenbroek, 2014, Long-term ketogenic diet causes glucose intolerance and reduced β- and α-cell mass but no weight loss in mice, Am J Physiol Metab, 306, E552
- Tay, 2014, A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: a randomized trial, Diabetes Care, 37, 2909, 10.2337/dc14-0845 · DOI · Paper page
- Kennedy, 2007, A high-fat, ketogenic diet induces a unique metabolic state in mice, Am J Physiol Metab, 292, E1724
- Veech, 2014, Ketone ester effects on metabolism and transcription, J. Lipid Res, 55, 2004, 10.1194/jlr.R046292 · DOI
- Holdsworth, 2017, A ketone ester drink increases postexercise muscle glycogen synthesis in humans, Med Sci Sport Exerc, 49, 1789, 10.1249/MSS.0000000000001292 · DOI
- Soto-Mota, 2019, Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults, Regul Toxicol Pharmacol, 109, 104506, 10.1016/j.yrtph.2019.104506 · DOI · Paper page
- Cuenoud, 2020, Metabolism of exogenous D-beta-hydroxybutyrate, an energy substrate avidly consumed by the heart and kidney, Front Nutr, 7, 13, 10.3389/fnut.2020.00013 · DOI
- Bleeker, 2020, Nutritional ketosis improves exercise metabolism in patients with very long-chain acyl-CoA dehydrogenase deficiency, J Inherit Metab Dis, 43, 787, 10.1002/jimd.12217 · DOI
Cited by
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF
Requena-Ibáñez, J. A., Santos-Gallego, C. G., Rodriguez-Cordero, A., Vargas-Delgado, A. P., Mancini, D., Sartori, S., Atallah-Lajam, F., Giannarelli, C., Macaluso, F., Lala, A., et al. (2021) · JACC: Heart Failure · doi:10.1016/j.jchf.2021.04.014 · Cited by 264
Self-citationGenome-wide characterization of circulating metabolic biomarkers
Karjalainen, M. K., Karthikeyan, S., Oliver-Williams, C., Sliz, E., Allara, E., Fung, W. T., Surendran, P., Zhang, W., Jousilahti, P., Kristiansson, K., et al. (2024) · Nature · doi:10.1038/s41586-024-07148-y · Cited by 261
Alternative Dietary Patterns for Americans: Low-Carbohydrate Diets
Volek, J. S., Phinney, S. D., Krauss, R. M., Johnson, R. J., Saslow, L. R., Gower, B., Yancy, W. S., King, J. C., Hecht, F. M., Teicholz, N., et al. (2021) · Nutrients · doi:10.3390/nu13103299 · Cited by 57
Biesiekierska, M., Strigini, M., Śliwińska, A., Pirola, L., & Balcerczyk, A. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf010 · Cited by 18
Landgraf, R., Aberle, J., Birkenfeld, A. L., Gallwitz, B., Kellerer, M., Klein, H., Müller-Wieland, D., Nauck, M. A., Wiesner, T., & Siegel, E. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1624-3449 · Cited by 12
Metadata
- Authors
- Yurista, S. R., Chong, C.-R., Badimon, J. J., Kelly, D. P., de Boer, R. A., & Westenbrink, B. D.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 77
- Issue
- 13
- Pages
- 1660-1669
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W3129301210
- Cited by
- 226
- References
- 11
- FWCI
- 19.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- National Health and Medical Research Council (GNT1162356)
- Hartstichting
- Pfizer
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (2019T064, 016.176.147)
- Amgen
- Roche
- Janssen Pharmaceuticals
- National Heart Foundation of Australia (102126)
- European Research Council (818715)
- National Institutes of Health (R01 HL058493, HL151345, HL128349)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease. https://app.cochat.ai/papers/10.1016/j.jacc.2020.12.065
- The paper
- Yurista, S. R., Chong, C.-R., Badimon, J. J., Kelly, D. P., de Boer, R. A., & Westenbrink, B. D. (2021). Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2020.12.065
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.